Interferon drives hepatitis C virus scarring of the epigenome and creates targetable vulnerabilities following viral clearance.

Integration of epigenetic and transcriptional data elucidates key gene deregulation events driven by HCV infection and how this may underpin the long-term elevated risk for HCC in patients cured of HCV due to epigenome scarring.